Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Total Debt (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Total Debt for 6 consecutive years, with $57.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 7.55% year-over-year to $57.3 million, compared with a TTM value of $57.3 million through Dec 2025, up 7.55%, and an annual FY2025 reading of $57.3 million, up 7.55% over the prior year.
  • Total Debt was $57.3 million for Q4 2025 at Treace Medical Concepts, up from $53.5 million in the prior quarter.
  • Across five years, Total Debt topped out at $57.3 million in Q4 2025 and bottomed at $29.2 million in Q1 2021.
  • Average Total Debt over 5 years is $47.3 million, with a median of $52.9 million recorded in 2023.
  • The sharpest move saw Total Debt fell 5.2% in 2021, then soared 79.53% in 2022.
  • Year by year, Total Debt stood at $29.4 million in 2021, then surged by 79.5% to $52.7 million in 2022, then increased by 0.56% to $53.0 million in 2023, then increased by 0.56% to $53.3 million in 2024, then rose by 7.55% to $57.3 million in 2025.
  • Business Quant data shows Total Debt for TMCI at $57.3 million in Q4 2025, $53.5 million in Q3 2025, and $53.5 million in Q2 2025.